Azstarys (re-)born with Collegium’s ADHD buy

AI Briefing

• – Collegium Pharmaceutical Inc. acquires Azstarys from Corium Therapeutics Holdings LLC, a treatment for ADHD.
• – The deal is expected to protect Collegium's revenue stream in the ADHD market.
• – The purchase price was not disclosed.